You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
No big surprise here: a series of trials claim that pharmas downplayed adverse effects of popular drugs. Is this is a harbinger of lawsuits to come as people find more knowledge in genomic and proteomic data?
Svante Paabo, now at the Max Planck Institute for Evolutionary Anthropology, gets the third-degree.
A recent Cell paper has been challenged, and the corresponding author's home university recommends that the paper be retracted. How much can you trust what you read?
Intel donates a supercomputer to the South Africa's Council for Scientific and Industrial Research.
Written protocols not your thing? Take out a subscription to the first video-based scientific journal.
High-performance chromatography gets a boost from the latest generation of monolith columns.
'Tis the season for NIH-sponsored databases, including NCI's Pathway Interaction Database and the NLM's Database of Genotype and Phenotype.
Nick Patterson made his name as a cryptologist in the Cold War -- and now spends his time trying to unravel the meaning of DNA.
Biomarker tests are catching the eye of mainstream media -- so it won't be long before consumers start asking questions. Are scientists ready with answers?
MRI scans are showing that many people with normal body weight are carrying around hidden stores of fat, which may be more about genes than snacking habits.
According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.
Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.
Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.
In Science this week: chromatin accessibility of microglia during fetal development, and more.